This is not the official budget document.

Budget Summary FY2016

Outside Section 181
Data Current as of:  8/19/2015




Previous Outside Section Next Outside Section

 

Task Force on the Bulk Purchase of Prescription Medications

SECTION 181.   There shall be a task force to investigate the impact on state agencies from joining a non-Medicaid, multi-state prescription drug bulk purchase consortium. The task force shall consider: (i) the estimated cost savings related to joining a non-Medicaid multistate prescription drug bulk purchase consortium; (ii) the opportunity for counties, municipalities and nonprofit organizations to participate in a non-Medicaid multistate prescription drug bulk purchase consortium; (iii) potential administrative savings and efficiencies for participants as a result of joining a non-Medicaid multistate prescription drug bulk purchase consortium; (iv) other bulk purchase discounts or rebates for prescription drugs, medical supplies or other medical goods purchased by state agencies, other governmental units and nonprofit organizations; and (v) the means of receiving rebates or discounts for medical supplies or medications not included under the federal 340B Drug Pricing Program for eligible entities. The task force may consider non-Medicaid multistate prescription drug bulk purchase consortiums that are not available to the group insurance commission.

The task force shall consist of: the commissioner of public health or a designee who shall serve as chair; the chief of pharmacy at the state office of pharmacy services or a designee; the commissioner of mental health or a designee; the commissioner of developmental services or a designee; the secretary of veterans' services or a designee; the commissioner of correction or a designee; the executive director of the group insurance commission or a designee; the attorney general or a designee; the president of the Massachusetts Sheriffs Association, Inc. or a designee; the president of the Massachusetts Biotechnology Council, Inc. or a designee; the chairperson of the Massachusetts Chamber of Commerce, Inc. or a designee; and 6 members to be appointed by the governor, 1 of whom shall be a health care economist, 1 of whom shall be a pharmacist registered by the board of registration of pharmacy, 1 of whom shall be a county or municipal representative, 1 of whom shall be a representative of a nonprofit community health center, 1 of whom shall be a patient advocate and 1 of whom shall have experience with multistate prescription drug bulk purchase consortiums. The task force shall file its report and any proposed legislation with the clerks of the house of representatives and the senate , the joint committee on health care financing and the house and senate committees on ways and means not later than March 1, 2016.
 

Veto Explanation:
I am vetoing this section because the Department of Public Health already employs a consolidated bulk buying plan for all state entities that purchase pharmaceuticals, and whether further advantages could be achieved by participating in a multi-state program of this sort is a question that can be settled without the creation of a new 13-member task force.